Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ACT-385781A (Actelion Epoprostenol)
(Prostacyclin)		[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
2Current marketed FLOLAN (epoprostenol sodium)
(Prostacyclin)		[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
3EPOPROSTENOL
(Prostacyclin)		[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
4Epoprostenol for injection
(Prostacyclin)		[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
5EPOPROSTENOL SODICO
(Prostacyclin)		[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
6EPOPROSTENOL SODIUM
(Prostacyclin)		[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
7Epoprostenol-Actelion
(Prostacyclin)		[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
8Inhaled prostacyclin[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
9New thermo stable formulation of epoprostenol sodium
(Prostacyclin)		[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
10Prostacyclin[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
11Prostacyclin Receptor Agonist[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
12Subcutaneous and intravenous prostacyclin[1] Epoprostenol (Prostacyclin)[1] Epoprostenol (Prostacyclin) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬